A groundbreaking study published in the open-access journal Open Heart illuminates the profound impact of synchronizing exercise regimens with an individual’s biological clock, or chronotype, on reducing cardiovascular disease risk among middle-aged adults already vulnerable to such conditions. This pioneering research investigates whether timing aerobic physical activity to align with a person’s innate morningness-eveningness preference can enhance health outcomes beyond those achieved by exercise alone.
Chronotype, an inherent propensity toward morning or evening alertness, dynamically influences a myriad of physiological processes including sleep-wake cycles, hormonal secretion, and energy availability throughout the day. These factors collectively modulate exercise performance and adherence, suggesting that not all workout timing is equally beneficial for every individual. Despite the known cardioprotective effects of exercise, the possibility that these benefits might vary depending on the temporal alignment of physical activity with one’s internal circadian rhythm has been less explored until now.
In this rigorous randomized controlled trial, researchers meticulously assessed chronotype in 150 participants aged 40 to 60 years. Utilizing the Morningness-Eveningness Questionnaire alongside continuous 48-hour core body temperature monitoring, the study precisely classified participants as either “morning larks” or “night owls.” This dual-method approach enhanced chronotype classification accuracy by integrating self-reported behavioral preferences with objective physiological markers governed by the circadian pacemaker.
All study participants manifested at least one cardiometabolic risk factor, including elevated blood pressure, overweight or obesity, or a sedentary lifestyle characterized by minimal recent structured physical activity. Additionally, a sizeable proportion—43%—had a familial predisposition to premature cardiovascular disease, defined stringently with respect to early onset in first-degree relatives. This well-defined inclusion criteria ensured the recruitment of a cohort representative of middle-aged adults at heightened cardiovascular risk.
Random allocation assigned individuals to perform moderate-intensity aerobic exercise, specifically brisk treadmill walking, either at a time congruent with their chronotype or at a discordant time period. Participants completed five 40-minute supervised sessions weekly, spanning morning hours (8:00 to 11:00) for morning types and evening hours (18:00 to 21:00) for evening types, or vice versa for mismatched groups. The 12-week intervention period allowed for both acute and cumulative adaptations to the exercise timing to manifest in physiological metrics.
Remarkably, 134 participants completed the trial, with a distribution of 70 morning types (34 matched, 36 mismatched) and 64 evening types (30 matched, 34 mismatched). Pre- and post-intervention assessments included comprehensive cardiometabolic profiling: resting blood pressure, heart rate variability reflecting autonomic nervous system balance, fasting plasma glucose, maximal oxygen consumption (VO₂ max) during exertion, LDL cholesterol quantification, and subjective sleep quality evaluation through validated measures.
The data underscored compelling improvements across both time-aligned and misaligned exercise groups, affirming exercise’s well-established benefits. However, those engaged in chronotype-aligned exercise exhibited significantly enhanced reductions in systolic blood pressure—a critical cardiovascular risk determinant—with an average decrease of 10.8 mm Hg compared to only 5.5 mm Hg in the non-aligned cohorts. This antihypertensive effect was accentuated among participants initially hypertensive, with systolic pressure dipping by 13.6 mm Hg versus 7.1 mm Hg for their mismatched counterparts.
Similarly, improvements in autonomic function, as reflected by heart rate variability indices, and aerobic capacity, quantified by VO₂ max, were notably greater when exercise was synchronized with internal biological rhythms. Metabolic markers such as fasting glucose and LDL cholesterol also demonstrated more pronounced favorable shifts in the chronotype-aligned group. Perhaps most strikingly, sleep quality—a pervasive yet often underemphasized component of cardiometabolic health—showed a threefold enhancement in alignment groups versus minimal gains in mismatched exercisers.
Interestingly, the magnitude of these benefits appeared more substantial among morning types than evening types, suggesting potential differential responsiveness to chrono-exercise interventions based on circadian phenotype. Notwithstanding, the overall pattern advocates for a personalized approach to exercise timing informed by circadian biology to maximize therapeutic efficacy for cardiometabolic risk reduction.
The investigators candidly acknowledged the study’s contextual confines. The participant pool was restricted to patients from government hospitals in Lahore, Pakistan, potentially limiting generalizability to other ethnically and socioeconomically diverse populations. Furthermore, individuals with intermediate chronotypes were excluded to achieve clearer dichotomization, which may curtail applicability to the full chronotype spectrum. Despite these limitations, the findings resonate with burgeoning literature emphasizing the role of circadian alignment in health optimization.
Mechanistically, the researchers hypothesize that exercising in concordance with the internal clock optimizes entrainment of peripheral clocks located within skeletal muscle, adipose tissue, and vascular structures. Such synchronization may enhance metabolic efficiency and mitigate low-grade systemic inflammation, both of which are pivotal in the pathogenesis of cardiometabolic diseases. This concept of “chrono-exercise” extends the principles of chronotherapy into lifestyle interventions, promising an impactful paradigm shift in preventive cardiovascular medicine.
Experts like Dr. Rajiv Sankaranarayanan of the British Cardiovascular Society highlight the practical implications of these results within healthcare systems such as the NHS, where scalable and cost-effective preventive strategies are paramount. Chronotype assessments could be integrated simply into routine clinical evaluations, enabling tailored exercise prescriptions that bolster patient adherence and amplify health outcomes, particularly in populations burdened by hypertension and metabolic syndrome.
Nevertheless, Dr. Sankaranarayanan underscores the necessity for validation studies in more heterogeneous cohorts, including shift workers and ethnically diverse groups, before routine implementation. As circadian biology continues to elucidate its broad influence on human physiology, personalized chrono-exercise regimens appear poised to become central components of comprehensive cardiometabolic risk management.
In conclusion, this pivotal trial substantiates the notion that not only the dose and intensity but also the timing of aerobic exercise relative to individual chronotype can significantly modify cardiovascular and metabolic health trajectories. Integrating circadian-informed exercise timing into preventive strategies may inaugurate a new frontier in personalized medicine, harnessing the body’s intrinsic rhythms to combat the escalating burden of cardiometabolic diseases globally.
Subject of Research: People
Article Title: Chronotype-aligned exercise timing in middle-aged adults at cardiometabolic risk: a randomised controlled trial
News Publication Date: 14-Apr-2026
Web References: http://dx.doi.org/10.1136/openhrt-2025-003573
Keywords: Biological rhythms, Physical exercise, Metabolic disorders, Cardiovascular disorders, Hypertension, Sleep disorders
